Abstract
The early success of recombinant DNA technology relies heavily on the elucidation of the biological possesses at the molecular level in microbial systems. The first commercial application is realized in the microbial production of human insulin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Chapter 16: Microbial Production of Recombinant Human Insulin
Atkinson, M. A., and Maclaren, N. K. 1990. What causes diabetes? Sci. Am. 263(1), 62–71.
Bristow, A. F. 1993. Recombinant-DNA-derived insulin analogues as potentially useful therapeutic agents. Trends Biotechnol. 11, 301–305.
Gilbert, W., and Willa-Komaroff, L. 1980. Useful proteins from recombinant bacteria. Sci. Am. 242(4), 74–94.
Goeddel, D. V., Kleid, D. G., Bolivar, F., Heyneker, H. L., Yansura, D. G., Crea, R., Hirose, T., Kraszewski, A., Itakura, K., and Riggs, A. D. 1979. Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc. Natl. Acad. Sci. USA 76, 106–110.
Lienhard, G. E., Slot, J. S., James, D. E., and Mueckler, M. M. 1992. How cells absorb glucose? Sci. Am. 266(1), 86–91.
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
(2006). Microbial Production of Recombinant Human Insulin. In: The ABCs of Gene Cloning. Springer, Boston, MA. https://doi.org/10.1007/0-387-28679-9_16
Download citation
DOI: https://doi.org/10.1007/0-387-28679-9_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-28663-1
Online ISBN: 978-0-387-28679-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)